CD2AP and renal fibrosis: Research indicates that urinary release of podocyte-derived exosomal CD2AP mRNA is negatively correlated with the extent of renal fibrosis and glomerulosclerosis, suggesting that CD2AP mRNA could serve as a noninvasive tool to detect renal fibrosis (59).